Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In-vitro gene signature of NHEK's treated with caspase inhibitor Q-VD-Oph or DMSO

ABSTRACT: In-vitro gene signature of NHEK's treated with caspase inhibitor Q-VD-Oph or DMSO

PROVIDER: PRJNA885441 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21753351_1.fastq.gz	Fastqsanger.gz
	SRR21753351_2.fastq.gz	Fastqsanger.gz
	SRR21753352_1.fastq.gz	Fastqsanger.gz
	SRR21753352_2.fastq.gz	Fastqsanger.gz
	SRR21753353_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

In-vitro gene signature of NHEK's treated with caspase inhibitor Q-VD-Oph or DMSO

Project description:To investigate the effect of caspase inibition in human keratinocytes

2025-02-08 | GSE214452 | GEO

In vitro gene signature of keratinocytes

Project description:In vitro gene signature of keratinocytes

| PRJNA476916 | ENA

Human TNBC Cells 48h Treatment with OTSSP167 MELK Inhibitor vs. DMSO Control

Project description:Microarray comparing TNBC cells treated for 48 hours with OTSSp167 MELK Inhibitor and control (DMSO)

2017-05-01 | GSE68652 | GEO

Single cell RNA-Seq of wild type and caspase inhibitor treated mouse embryos at the stage E6.5

Project description:We investigated the features of cells eliminated during early mouse embryogenesis by means of Single Cell RNA-Sequencing (RNA-Seq). To enrich for apoptotic cells, we treated a number of embryos with caspase inhibitor, and then collected and sequenced single-cells isolated from them.

2020-01-17 | E-MTAB-8640 | biostudies-arrayexpress

Human TNBC Cells 72h Treatment with 45nM OTSSP167 MELK Inhibitor vs. DMSO Control

Project description:Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO)

2017-05-01 | GSE68692 | GEO

Human TNBC Cells 72h Treatment with 4.5nM OTSSP167 MELK Inhibitor vs. DMSO Control

Project description:Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO)

2017-05-01 | GSE68691 | GEO

Human TNBC Cells 48h Treatment with OTSSP167 MELK Inhibitor vs. DMSO Control

Project description:Microarray comparing TNBC cells treated for 48 hours with OTSSp167 MELK Inhibitor and control (DMSO) Two-condition arrays: MDA-MB-231 cells were treated with either 4.5nM OTSSP167 MELK Inhibitor or 0.045% DMSO for 48h. Two biological replicates, one per array, with a dye swap (technical replicate).

2017-05-01 | E-GEOD-68652 | biostudies-arrayexpress

Human TNBC Cells 72h Treatment with 45nM OTSSP167 MELK Inhibitor vs. DMSO Control (SUM159)

Project description:Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO)

2017-05-01 | GSE71027 | GEO

Human TNBC Cells 72h Treatment with 4.5nM OTSSP167 MELK Inhibitor vs. DMSO Control (SUM159)

Project description:Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO)

2017-05-01 | GSE71026 | GEO

Human TNBC Cells 72h Treatment with 45nM OTSSP167 MELK Inhibitor vs. DMSO Control

Project description:Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO) Two-condition arrays: MDA-MB-231 cells were treated with either 45nM OTSSP167 MELK Inhibitor or 0.045% DMSO for 72h. Two biological replicates, one per array, with a dye swap (technical replicate).

2017-05-01 | E-GEOD-68692 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data